SpaceX shares have cratered 39% from their Day-1 peak of $176.52, leaving early retail investors deep underwater. Financial expert Suze Orman warns that overpaying for hyped IPOs is a recurring trap, advising investors to wait at least two earnings cycles before committing capital to newly public companies.
SpaceX shares have experienced significant volatility following their IPO, with retail investors who bought at the $176.52 intraday high suffering a 39% loss within seven weeks. Suze Orman and analysts like Keith Snyder highlight that the stock was significantly overvalued at launch, exacerbated by negative free cash flow and a massive influx of insider shares hitting the market through December 2026. Consequently, experts recommend waiting for two earnings cycles to allow for price stabilization and better visibility into the company's financial trajectory.
- ▼ Strong Q2 revenue performance of $7.8 billion beating estimates
- ▼ Potential long-term upside with a median 12-month analyst price target of $217
- ▲ Negative free cash flow of $25 billion in the first half of 2026
- ▲ Significant share dilution as the float increases from 1.8 billion to 5.2 billion shares by December 2026
▼ Show FAQ (2) ▲ Hide FAQ
Why does Suze Orman suggest waiting two earnings cycles?
Waiting allows investors to see a clear revenue trajectory, evaluate management's track record, and observe the impact of insider lockup expirations.
What is the primary risk of buying SpaceX at its IPO peak?
Early buyers often pay a premium that ignores historical IPO trends, where stocks frequently drop an average of 34% within their first year.